Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REenergizeME: Oxygen Therapy (OT) as a Novel Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

NCT07317401 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT07317401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07317401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REenergizeME: Oxygen Therapy (OT) as a Novel Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
January 1, 2029
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) (icd-10 g93.3)